↓ Skip to main content

Targeting Epigenetic Mechanisms for Chronic Pain: A Valid Approach for the Development of Novel Therapeutics

Overview of attention for article published in The Journal of Pharmacology and Experimental Therapeutics, January 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
96 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting Epigenetic Mechanisms for Chronic Pain: A Valid Approach for the Development of Novel Therapeutics
Published in
The Journal of Pharmacology and Experimental Therapeutics, January 2016
DOI 10.1124/jpet.115.231670
Pubmed ID
Authors

Casey O. Ligon, Rachel D. Moloney, Beverley Greenwood-Van Meerveld

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 96 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 26 27%
Student > Ph. D. Student 16 17%
Student > Bachelor 15 16%
Researcher 9 9%
Student > Master 7 7%
Other 7 7%
Unknown 16 17%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 27 28%
Agricultural and Biological Sciences 17 18%
Medicine and Dentistry 13 14%
Neuroscience 7 7%
Nursing and Health Professions 3 3%
Other 10 10%
Unknown 19 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2016.
All research outputs
#16,681,672
of 26,017,215 outputs
Outputs from The Journal of Pharmacology and Experimental Therapeutics
#4,403
of 5,743 outputs
Outputs of similar age
#228,076
of 408,886 outputs
Outputs of similar age from The Journal of Pharmacology and Experimental Therapeutics
#28
of 47 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,743 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 408,886 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.